Literature DB >> 20824715

Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers.

Guillaume Sarrabayrouse1, Murielle Corvaisier, Laure-Hélène Ouisse, Céline Bossard, Bernard Le Mével, Lucien Potiron, Guillaume Meurette, Nadine Gervois, Francine Jotereau.   

Abstract

High level of T-cell infiltration in colorectal carcinomas (CRCs) is a good prognostic indicator, but the tumor reactivity of this infiltrate (tumor infiltrating lymphocytes [TIL]) is poorly documented. This study examined the presence, phenotype and functional features of tumor-reactive lymphocytes in human CRC. Freshly dissociated TIL and T cell lines were isolated from CRC samples and from some paired normal colonic mucosa. Four tumor cell lines were obtained. Autologous tumor reactivity of CRC TIL and tumor-reactive cell features were analyzed. We demonstrate the presence among CRC TIL of variable fractions (up to 18%) of double positive CD4(+) CD8αβ(+) (DP) αβ T cells. Interestingly, a high proportion (16-20%) of this TIL subset displayed tumor reactivity, whilst this was the case for no or few single positive TIL. Low levels of DP TIL were found in most CRC samples and in normal colonic mucosa, but these cells were higher in metastatic CRC. Furthermore, we showed that DP TIL were polyclonal, restricted by HLA class-I, proliferated poorly and secreted higher amounts of IL-4 and IL-13 than single positive T cells, on cognate or CD3 stimulation. DP CRC TIL also expressed CD103, confirming their mucosal origin. Increased frequencies of tumor-reactive DP TIL in metastatic CRC suggest that these cells play a role in the metastatic process of this cancer. Based on their high secretion of IL-4 and IL-13 and on previously described roles of these cytokines in cancers, we postulate that DP TIL could favor CRC growth or metastasis and/or downmodulate immune responses to these tumors.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824715     DOI: 10.1002/ijc.25640

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.

Authors:  Yan Liu; Yoshihiro Komohara; Natalie Domenick; Masasuke Ohno; Maki Ikeura; Ronald L Hamilton; Craig Horbinski; Xinhui Wang; Soldano Ferrone; Hideho Okada
Journal:  Cancer Immunol Immunother       Date:  2011-11-08       Impact factor: 6.968

Review 2.  Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

Authors:  F Jotereau; N Gervois; N Labarrière
Journal:  Target Oncol       Date:  2012-02-15       Impact factor: 4.493

3.  Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

Authors:  T Tomic; T Botton; M Cerezo; G Robert; F Luciano; A Puissant; P Gounon; M Allegra; C Bertolotto; J-M Bereder; S Tartare-Deckert; P Bahadoran; P Auberger; R Ballotti; S Rocchi
Journal:  Cell Death Dis       Date:  2011-09-01       Impact factor: 8.469

4.  CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Authors:  Guillaume Sarrabayrouse; Céline Bossard; Joe-Marc Chauvin; Anne Jarry; Guillaume Meurette; Elodie Quévrain; Chantal Bridonneau; Laurence Preisser; Karim Asehnoune; Nathalie Labarrière; Frédéric Altare; Harry Sokol; Francine Jotereau
Journal:  PLoS Biol       Date:  2014-04-08       Impact factor: 8.029

5.  CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells.

Authors:  Tiphaine Parrot; Romain Oger; Houssem Benlalam; Diane Raingeard de la Blétière; Nicolas Jouand; Anne Coutolleau; Laurence Preisser; Amir Khammari; Brigitte Dréno; Philippe Guardiola; Yves Delneste; Nathalie Labarrière; Nadine Gervois
Journal:  Oncoimmunology       Date:  2016-10-28       Impact factor: 8.110

6.  Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15.

Authors:  Marie-Laure Clénet; François Gagnon; Ana Carmena Moratalla; Emilie C Viel; Nathalie Arbour
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

7.  CD4hiCD8low Double-Positive T Cells Are Associated with Graft Rejection in a Nonhuman Primate Model of Islet Transplantation.

Authors:  Yun Jung Choi; Hi-Jung Park; Hye Jin Park; Kyeong Cheon Jung; Jae-Il Lee
Journal:  J Immunol Res       Date:  2018-07-10       Impact factor: 4.818

8.  Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.

Authors:  Laurence C Menard; Paul Fischer; Bijal Kakrecha; Peter S Linsley; Erik Wambre; Maochang C Liu; Blake J Rust; Deborah Lee; Becky Penhallow; Nataly Manjarrez Orduno; Steven G Nadler
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

9.  Increased CD4+CD8+ Double-Positive T Cell in Patients with Primary Sjögren's Syndrome Correlated with Disease Activity.

Authors:  Sen Wang; Han Shen; Bing Bai; Jia Wu; Junjun Wang
Journal:  J Immunol Res       Date:  2021-05-14       Impact factor: 4.818

Review 10.  Cytokine-Induced Modulation of Colorectal Cancer.

Authors:  Lukas F Mager; Marie-Hélène Wasmer; Tilman T Rau; Philippe Krebs
Journal:  Front Oncol       Date:  2016-04-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.